JEOL USA Press Releases

JEOL USA Press Releases

rss

JEOL USA Press Releases

NJBio-JEOL.jpg

NJ Biopharmaceuticals LLC and JEOL Ltd. Are Excited to Announce Their Collaboration to Bring Innovative Drug Discovery Platform Solutions Using JEOL’s 800 MHz NMR!

We're excited to share the news that NJ Bio is procuring an 800 MHz NMR spectrometer with a cryogenic probe from JEOL. As part of this collaboration, NJ Bio will contribute its expertise in antibody drug conjugates, oligonucleotide conjugates, and other chemistries to develop platform solutions for its drug discovery clients - in particular, a platform for using NMR-derived structural information to optimize Targeted Protein Degraders (TPDs). JEOL has world-class capability in NMR and will provide technical expertise to maximize the performance of the 800 MHz NMR in these drug discovery applications.

Learn more about this Press Release from NJ Bio



Comments are closed.